| 2025 | Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204)
| BMC CANCER |
| 2025 | Choosing Wisely between Radiotherapy Dose-Fractionation Schedules: The Molecular Graded Prognostic Assessment for Elderly Glioblastoma Patients
| CANCER RESEARCH AND TREATMENT |
| 2025 | Prognostic models for progression-free survival in atypical meningioma: Comparison of machine learning-based approach and the COX model in an Asian multicenter study | RADIOTHERAPY AND ONCOLOGY |
| 2025 | To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-Type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy
| CANCER RESEARCH AND TREATMENT |
| 2024 | The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center
| RADIATION ONCOLOGY JOURNAL |
| 2024 | Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03 | GYNECOLOGIC ONCOLOGY |
| 2024 | Clinical indications and future directions of carbon- ion radiotherapy: a narrative review
| EWHA MEDICAL JOURNAL |
| 2024 | Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinoma
| FRONTIERS IN ONCOLOGY |
| 2024 | Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02) | NEUROSURGERY |
| 2024 | De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkers
| NEURO-ONCOLOGY ADVANCES |
| 2023 | Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
| Journal of Urologic Oncology |
| 2023 | Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
| BMC CANCER |
| 2023 | The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Survey About Specific Clinical Scenarios (Version 2023.1)
| Brain Tumor Research and Treatment |
| 2023 | The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.3)
| Brain Tumor Research and Treatment |
| 2023 | Dose-response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy | JOURNAL OF NEURO-ONCOLOGY |
